Appointment announcement

15 December 2015
Volume 31 · Issue 6

Calcivis, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, recently announced it has appointed Peter Rees as non-executive board director. 

Peter’s extensive experience of the dental market, in particular his demonstrated track record in sales and marketing and product launches, makes him an ideal advisor for Calcivis.

The Calcivis Caries Activity Imaging System will, for the first time, allow the real time detection and visualisation of calcium ions released by demineralising caries lesions in routine dental practice.

Peter brings 23 years of experience in the dental and medical device sector built upon his medical and sales and marketing experience. As a VP and general manager of Dentsply Ltd, the company became the UK’s leading manufacturer of dental products during his 11 year tenure during which sales increased by over 50 per cent. Latterly as managing director of ReeSearch, Peter was instrumental in successfully launching a pharmaceutical product to the dental market. He is currently a consultant and part time interim chief executive officer of Hambley Ltd, a company specialising in the design and development of products for dental and medical industry.

Peter holds a BSc (Hons) in Applied Biochemistry from the University of Liverpool John Moores and a Diploma in Dental Studies.

“We are delighted to welcome Peter to our team” said Adam Christie, CEO of Calcivis. “Peter brings a wealth of experience and customer insight in the dental market and will be invaluable in advising us on our commercial strategy as we start to bring our novel, transformative product to the market in late 2016.”

Peter commented: “I am excited to be advising Calcivis on its marketing strategy and upcoming product launch given its potential to transform the way we manage tooth decay in the dental market. I have been extremely impressed by senior management and am delighted to be joining the team as a non-executive board director.”